Aytu Biopharma AYTU
NASDAQ AYTU
$1.94 -0.04 (-2.03%)
As of: Oct 23, 2026 · 3:43 PM EDT

Aytu Biopharma (AYTU) Amortization of Deferred Charges (2016 - 2026)

Updated

Analysis

Aytu Biopharma (AYTU) Amortization of Deferred Charges (2016 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,133.26 Bn 1,101.85 Bn 19.71 Bn
2 Johnson & Johnson 635.92 Bn 555.78 Bn 17.30 Bn
3 AbbVie 506.32 Bn 479.44 Bn 12.70 Bn
4 Merck 358.38 Bn 312.76 Bn 12.21 Bn
5 Novartis Ag 293.00 Bn 256.99 Bn 11.24 Bn
6 Astrazeneca 265.76 Bn 239.44 Bn 12.86 Bn
7 Amgen 237.88 Bn 193.27 Bn 7.24 Bn
8 Gilead Sciences 195.26 Bn 169.45 Bn 6.22 Bn
9 Pfizer 171.34 Bn 117.99 Bn 10.94 Bn
10 Aytu Biopharma 23.90 Mn -91.78 Mn 10.41 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 28,000.00
Mar 31, 2026 27,000.00
Dec 31, 2025 29,000.00
Sep 30, 2025 29,000.00
Jun 30, 2025 26,000.00
Mar 31, 2025 27,000.00
Dec 31, 2024 28,000.00
Sep 30, 2024 27,000.00
Jun 30, 2024 134,000.00
Mar 31, 2024 161,000.00
Dec 31, 2023 154,000.00
Sep 30, 2023 148,000.00
Jun 30, 2023 146,000.00
Mar 31, 2023 98,000.00
Dec 31, 2022 170,000.00
Sep 30, 2022 145,000.00
Jun 30, 2022 142,000.00
Mar 31, 2022 100,000.00
Dec 31, 2021 -165,000.00
Sep 30, 2021 -161,000.00
API Access

Aytu Biopharma Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=AYTU&period=max&api_key=YOUR_API_KEY